IDEAYA Biosciences, Inc.

IDYA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$84,378$157,018$68,632$92,046
Short-Term Investments$591,941$368,096$296,197$154,724
Receivables$3$18$211$1,103
Inventory$0$0$0$0
Other Curr. Assets$13,391$7,500$5,414$3,123
Total Curr. Assets$689,713$532,632$370,454$250,996
Property Plant & Equip (Net)$27,741$8,410$8,993$8,661
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$405,832$107,492$8,317$121,293
Tax Assets$0$0$0$0
Other NC Assets$805$782$205$397
Total NC Assets$434,378$116,684$17,515$130,351
Other Assets$0$0$0$0
Total Assets$1,124,091$649,316$387,969$381,347
Liabilities
Payables$15,421$6,598$4,280$2,100
Short-Term Debt$298$1,747$1,871$1,699
Tax Payable$0$0$0$0
Deferred Revenue$0$0$8,568$29,040
Other Curr. Liab.$30,352$18,756$16,999$12,320
Total Curr. Liab.$46,071$27,101$31,718$45,159
LT Debt$18,873$1,125$1,611$3,482
Deferred Rev, NC$0$0$5,185$31,192
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$18,873$1,125$6,796$34,674
Other Liabilities$0$0$0$0
Cap. Leases$19,171$2,872$3,482$5,181
Total Liabilities$64,944$28,226$38,514$79,833
Equity
Pref Stock$0$0$0$0
Common Stock$9$7$5$4
Retained Earnings-$622,841-$348,364-$235,403-$176,748
AOCI$812$562-$2,871-$712
Other Equity$1,681,167$968,885$587,724$478,970
Total Equity$1,059,147$621,090$349,455$301,514
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,124,091$649,316$387,969$381,347
Net Debt-$65,207-$154,146-$65,150-$86,865